Clinical trials
Parkinson Disease trials in Germany with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 14 |
| Recruiting | 10 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boston Scientific Corporation | 5 |
| University Hospital Tuebingen | 4 |
| Charite University, Berlin, Germany | 3 |
| University Hospital Muenster | 3 |
| University of Erlangen-Nürnberg | 3 |
| University of Kiel | 3 |
| KU Leuven | 2 |
| RWTH Aachen University | 2 |
| Technische Universität Dresden | 2 |
| Abbott Medical Devices | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 50 |
| Neurodegenerative Diseases | 4 |
| Parkinsonian Disorders | 4 |
| Cognitive Dysfunction | 3 |
| Deglutition Disorders | 3 |
| Movement Disorders | 3 |
| Basal Ganglia Diseases | 2 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Dementia | 2 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.